Human Genome Reverses Losses

April 30, 2009 1:55 PM |
Human Genome Sciences Inc. (NYSE: HGSI) reversed year ago losses of 39 cents per share to post a profit of 85 cents per share for the first quarter due to sales of its anthrax treatment sending the stock price soaring 80 cents to close at $2.19.

Tags:

Search

About this Entry

This page contains a single entry by published on April 30, 2009 1:55 PM.

Expedia Tops Estimates was the previous entry in this blog.

DryShips Beats Expectations is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12